What Happened in the Coldrif Cough Syrup Tragedy?
Synopsis
Key Takeaways
- Investigation ongoing: The Special Investigation Team is actively probing the case.
- Public health concerns: The incident raises alarms about pharmaceutical safety.
- Multiple arrests: Several individuals, including a pediatrician, have been detained.
- Regulatory actions taken: The syrup has been banned in several states.
- Fatalities reported: Numerous children have tragically lost their lives due to the contaminated syrup.
Chhindwara, Nov 13 (NationPress) The Special Investigation Team (SIT) of the Madhya Pradesh Police, currently probing the Coldrif cough syrup incident, has taken Praveen Soni, a key suspect in the case, into custody for a duration of three days.
The SIT arrived at the Chhindwara jail on Thursday, and shortly after, they left with Soni in their custody.
Sources within the police informed IANS that Soni was transported to the Parasia police station in the Chhindwara district, where he will face questioning for the next three days.
According to police sources, this action is part of the ongoing investigation, and the SIT had previously submitted a request to the Chhindwara jail for Soni's custody.
Soni, a senior pediatrician, had prescribed the contaminated cough syrup that is believed to have resulted in the deaths of 25 children in Chhindwara and surrounding areas. He was apprehended on October 5 after an FIR was lodged against him and has since been held at the Chhindwara jail.
Recently, the SIT also detained Soni's wife, Jyoti Soni, who owns a pharmacy linked to Soni's private hospital in the Parasia block of Chhindwara, where many children received prescriptions for the Coldrif syrup.
The Madhya Pradesh Police have arrested a total of seven individuals in this case, including G. Ranganathan, the owner of Sresan Pharmaceuticals in Tamil Nadu, along with several associates connected to the medicine's supply chain in Madhya Pradesh.
Tragically, 26 children from Chhindwara, Pandhurna, and Betul districts, primarily under the age of five, died due to kidney failure after ingesting the Coldrif cough syrup.
Moreover, at least three children in neighboring Rajasthan also succumbed after consuming the syrup.
This calamity led the World Health Organization to issue a warning against three 'substandard' oral cough syrups identified in India: Coldrif, Respifresh TR, and ReLife.
Tests conducted by the Madhya Pradesh government revealed that Coldrif contained 48.6 percent diethylene glycol, a hazardous chemical, vastly surpassing the permissible limit of 0.1 percent.
In light of the fatalities, the syrup has been banned in Tamil Nadu, Madhya Pradesh, Kerala, Karnataka, Punjab, Himachal Pradesh, Uttar Pradesh, Puducherry, West Bengal, and Delhi.